Mirae Asset Global Investments Co., Ltd. Janux Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,548 shares of JANX stock, worth $76,564. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,548Holding current value
$76,564% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding JANX
# of Institutions
161Shares Held
36.8MCall Options Held
72.2KPut Options Held
103K-
Ra Capital Management, L.P. Boston, MA9.17MShares$453 Million5.79% of portfolio
-
Orbimed Advisors LLC San Diego, CA2.98MShares$147 Million3.01% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$116 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.33MShares$115 Million0.19% of portfolio
-
Janus Henderson Group PLC London, X01.8MShares$89.1 Million0.04% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $2.06B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...